Complement-Based Drug Development Summit leaderboard
  • Saturday, August 29, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 348

Author

Pharma Journalist 9027 posts 0 comments

FDA Approves Repatha (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial…

Sep 24, 2021
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Repatha (evolocumab) as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C)-lowering…
Read More...

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with…

Sep 23, 2021
AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialisastion of the proprietary self-amplifying RNA (saRNA) therapeutics…
Read More...

Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for…

Sep 23, 2021
Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced it has expanded its research collaboration with Columbia University. The research collaboration…
Read More...

Phenomenex Announces the Release of New Biozen SEC Size Exclusion Chromatography Columns

Sep 23, 2021
Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the successful launch of NEW Biozen SEC Size Exclusion…
Read More...

AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process…

Sep 23, 2021
Singapore's cancer population may benefit from improved access to cutting-edge clinical trials through InSite Feasibility - Oncoshot's new digital platform that facilitates the…
Read More...

Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency…

Sep 23, 2021
Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India…
Read More...

FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations

Sep 22, 2021
The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be…
Read More...

AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody…

Sep 22, 2021
AbCellera and Everest Medicines Limited announced that they have entered into a multi-year collaboration and license agreement to discover therapeutic antibodies for up to 10 targets…
Read More...

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and…

Sep 21, 2021
Johnson & Johnson announced new data reinforcing the strong and long-lasting protection of its COVID-19 vaccine. New data also showed that protection against COVID-19 increases when…
Read More...

Persephone Biosciences Inc. Announces Collaboration with Janssen Biotech, Inc.

Sep 21, 2021
Persephone Biosciences Inc., a privately held, data-driven microbiome-focused biotechnology company, announced that it has entered into a collaboration agreement with Janssen Biotech,…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • FDA Approves Tivicay PD for Infants With HIV
  • FDA Grants Rare Pediatric Disease Designation to ReviR’s RTX-117
  • FDA Approves Ziihera Combinations for HER2-Positive GEA
  • FDA Approves RASONQUE for Metastatic Pancreatic Cancer
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.